Amprius Celebrates Expansion of Its State-of-the-Art Silicon Nanowire Anode Megawatt Hour Manufacturing Line
Over 90 Attendees Enjoyed Key Partner Presentations on the Impact of Amprius’ Next-Generation Technology and an Exclusive Factory Tour for a Preview of Amprius’... Read more.
Pembina Pipeline Corporation Announces Closing of $1.28 Billion Bought Deal Offering of Subscription Receipts
CALGARY, Alberta–(BUSINESS WIRE)–Pembina Pipeline Corporation (“Pembina” or the “Company”) (TSX: PPL; NYSE: PBA) is pleased to... Read more.
Verato Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance
MCCLEAN, Va.–(BUSINESS WIRE)–Verato, the identity experts for healthcare, today announced that it has earned certified status by HITRUST for information... Read more.
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Endeavor BioMedicines, a clinical-stage company developing therapies for fibrotic disease and oncology, announced that the... Read more.
Global Smart Implant Technologies Growth Opportunity Analysis 2023 – Blockchain Technology Deployment for Patient Data Security and Biomimetic Coatings for Smart Implants – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Smart Implant Technologies” report has been added to ResearchAndMarkets.com’s offering.... Read more.
dSPACE at CES 2024: New Solutions for Data-Driven Development, Simulation, and Validation of Electric and Self-Driving Cars
PADERBORN, Germany & WIXOM, Mich.–(BUSINESS WIRE)–#CES2024–At CES 2024, dSPACE will show how electric and self-driving cars can get on the... Read more.
Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly’s Ultrasound-on-Chip™ Technology
Agreement with Mendaera represents the first Powered by Butterfly™ commercialization partnership. Partnership will bring Butterfly’s Ultrasound-on-Chip™ to... Read more.
Boston Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, MD, PhD, as Acting Chief Medical Officer as MASH Asset BOS-580 Accelerates in Phase 2 Clinical Program
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Boston Pharmaceuticals today announced the appointment of Juan Carlos Lopez-Talavera, M.D., Ph.D., as Acting Chief Medical... Read more.
Study Published in Nature Digital Medicine Shows Potential Predictive Power of Augmented Reality-based Cognitive and Functional Assessment for Alzheimer’s Disease
Groundbreaking RADAR-AD Study Reports the Potential of Machine Learning and Augmented Reality-based Digital Biomarkers in Alzheimer’s Detection WASHINGTON–(BUSINESS... Read more.
Oakcliff Capital Sends Letter to the Board of Gildan Activewear Calling for the Return of Glenn Chamandy as CEO
Believes the Board’s Actions Demonstrate the Need to Replace Chairman Donald Berg and to Appoint Shareholder Representatives to Ensure Alignment of All Stakeholders’... Read more.